八部门印发“人工智能+”重磅文件，利好AI医疗、AI生物制造！

Core Viewpoint - The Ministry of Industry and Information Technology, along with seven other departments, has issued the "Implementation Opinions on the 'Artificial Intelligence + Manufacturing' Special Action," aiming for significant advancements in AI technology and its application in manufacturing by 2027 [1][5]. Group 1: Key Objectives - By 2027, China aims to achieve a safe and reliable supply of key AI technologies, maintaining a leading position in industry scale and empowerment levels [5]. - The document outlines seven key tasks focused on innovation foundation, intelligence upgrading, product breakthroughs, and entity cultivation to promote mutual empowerment between AI technology and manufacturing applications [5]. Group 2: Focus Areas in AI and Manufacturing - The "Guidelines for AI Empowering Key Industries in Manufacturing" specifically highlights AI applications in healthcare, pharmaceuticals, and biomanufacturing [3][5]. - In the pharmaceutical sector, the focus includes enhancing intelligent research and supply management, building AI-driven platforms for drug discovery, and optimizing drug synthesis processes to reduce development time and costs [3][6]. - The biomanufacturing sector aims for comprehensive innovation, utilizing AI to discover high-performance biological components and optimize fermentation processes for industrial strains [7][8][10]. Group 3: Technological Advancements - The initiative emphasizes the development of surgical robots and intelligent diagnostic systems to accelerate innovation in smart medical equipment and its clinical application [4][10]. - It also encourages the development of intelligent systems across various sectors, including healthcare, education, finance, and law, while focusing on the commercialization of AR/VR devices and brain-computer interfaces for industrial inspection and remote healthcare [4][10].